Paper29564591
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A and 55 others. Acta Neuropathol, 2018. Cited by 253 papers, by iCite.
Cite this record
ConductScience Library. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Papers, record 29564591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29564591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Astrocytoma | Major topic |
| Brain Neoplasms | Major topic |
| Isocitrate Dehydrogenase | Major topic |
| Signal Transduction | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Child | |
| Child, Preschool | |
| Cyclin-Dependent Kinase Inhibitor p16 | |
| DNA Methylation | |
| DNA Modification Methylases | |
| DNA Repair Enzymes | |
| Female | |
| Histones | |
| Humans | |
| Infant | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Mitogen-Activated Protein Kinase Kinases | |
| Mutation | |
| Retrospective Studies | |
| Tumor Suppressor Proteins | |
| X-linked Nuclear Protein | |
| Young Adult |
Source PubMed
Cited by187
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 253 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42867718 | MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42867718 | PubMed |
| 42811745 | Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42811745 | PubMed |
| 42747321 | High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/42747321 | PubMed |
| 42742637 | Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42742637 | PubMed |
| 42708165 | Leptomeningeal Dissemination in TERT Promoter-mutant Anaplastic Pleomorphic Xanthoastrocytoma Responding to BRAF-MEK Inhibition: A Case Report. | NMC Case Rep J | 2026 | https://conductscience.org/library/papers/42708165 | PubMed |
| 42688800 | Spindle Cell Predominant Anaplastic Pleomorphic Xanthoastrocytoma (WHO Grade 3) With Focal Piloid Features: A Rare Case Study With Comprehensive Molecular Profiling. | Cureus | 2026 | https://conductscience.org/library/papers/42688800 | PubMed |
| 42527461 | MuTATE: an interpretable multi-endpoint machine learning framework for automated molecular subtyping in cancer. | Npj Health Syst | 2025 | https://conductscience.org/library/papers/42527461 | PubMed |
| 42294280 | High-grade astrocytoma with piloid features: a case report of comprehensive management. | Front Oncol | 2026 | https://conductscience.org/library/papers/42294280 | PubMed |
| 42189937 | MAPK-dependent release of GDNF from Schwann cells mediates tumor-independent pain in neurofibromatosis 1. | Sci Signal | 2026 | https://conductscience.org/library/papers/42189937 | PubMed |
| 42168657 | CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42168657 | PubMed |
| 42142152 | Clinical utility of sarcoma methylation classifiers in soft tissue sarcoma diagnosis. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42142152 | PubMed |
| 42120807 | Tectal glioma with pilocytic astrocytoma morphology carrying a histone H3 K27M mutation and malignant transformation: a literature review. | Brain Tumor Pathol | 2026 | https://conductscience.org/library/papers/42120807 | PubMed |
| 42088911 | Spinal high-grade astrocytoma with piloid features arising in a patient with molecularly confirmed cerebellar pilocytic astrocytoma. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42088911 | PubMed |
| 41955004 | Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses. | Oncotarget | 2026 | https://conductscience.org/library/papers/41955004 | PubMed |
| 41807027 | High-Grade Astrocytoma With Piloid Features: An Aggressive Clinicogenomic Entity Distinct From Pilocytic Astrocytoma. | J Korean Med Sci | 2026 | https://conductscience.org/library/papers/41807027 | PubMed |
| 41802222 | Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas. | J Neuropathol Exp Neurol | 2026 | https://conductscience.org/library/papers/41802222 | PubMed |
| 41464224 | Limitations of DNA Methylation Profiling in High-Grade Gliomas: Case Series. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41464224 | PubMed |
| 41366148 | Immunotherapy and targeted therapy for high grade gliomas: current and future directions. | J Neurooncol | 2025 | https://conductscience.org/library/papers/41366148 | PubMed |
| 41315743 | Patient-derived tumoroids recapitulate the morphologic and molecular features of pediatric brain tumors. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41315743 | PubMed |
| 41122675 | Insights into an uncommon brain tumor with NTRK gene fusion: Glioneuronal tumor with ATRX alteration, kinase fusion, and anaplastic features. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/41122675 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATRX | 546 | PubTator's text mining | https://conductscience.org/library/genes/546 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CDKN2B | 1030 | PubTator's text mining | https://conductscience.org/library/genes/1030 | NCBI Gene |
| FGFR1 | 2260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| IDH2 | 3418 | PubTator's text mining | https://conductscience.org/library/genes/3418 | NCBI Gene |
| MGMT | 4255 | PubTator's text mining | https://conductscience.org/library/genes/4255 | NCBI Gene |
| NF1 | 4763 | PubTator's text mining | https://conductscience.org/library/genes/4763 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29564591
GET https://conductscience.org/api/papers/v1/29564591/authors?page=2